TrialArthritis & rheumatology (Hoboken, N.J.)2014

Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.

Rohit Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.